Investors sold shares of Clorox Co. (NYSE:CLX) on strength during trading hours on Tuesday. $25.29 million flowed into the stock on the tick-up and $39.00 million flowed out of the stock on the tick-down, for a money net flow of $13.71 million out of the stock. Of all companies tracked, Clorox had the 0th highest net out-flow for the day. Clorox traded up $0.77 for the day and closed at $123.44

Several research analysts recently weighed in on CLX shares. Atlantic Securities upgraded shares of Clorox from a “hold” rating to a “buy” rating and set a $144.00 price target for the company in a research report on Friday, September 16th. Citigroup Inc. upped their price target on shares of Clorox from $134.00 to $144.00 and gave the stock a “neutral” rating in a research report on Monday, August 8th. Goldman Sachs Group Inc. restated a “neutral” rating and set a $130.00 price target on shares of Clorox in a research report on Thursday, August 4th. Zacks Investment Research upgraded shares of Clorox from a “hold” rating to a “buy” rating and set a $148.00 price target for the company in a research report on Monday, August 8th. Finally, Deutsche Bank AG restated a “hold” rating and set a $134.00 price target (up previously from $130.00) on shares of Clorox in a research report on Sunday, July 24th. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of $128.90.

The stock has a market capitalization of $15.98 billion, a price-to-earnings ratio of 25.09 and a beta of 0.33. The firm’s 50 day moving average is $129.50 and its 200-day moving average is $130.10.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/21/traders-sell-shares-of-clorox-co-clx-on-strength-clx.html

Clorox (NYSE:CLX) last announced its earnings results on Wednesday, August 3rd. The company reported $1.26 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.28 by $0.02. The business had revenue of $1.60 billion for the quarter, compared to analyst estimates of $1.58 billion. Clorox had a return on equity of 296.91% and a net margin of 11.25%. The business’s revenue was up 2.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.44 EPS. Equities analysts forecast that Clorox Co. will post $5.49 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Monday, November 14th. Shareholders of record on Wednesday, October 26th will be given a dividend of $0.80 per share. This represents a $3.20 dividend on an annualized basis and a yield of 2.59%. The ex-dividend date is Monday, October 24th. Clorox’s payout ratio is currently 64.91%.

In other Clorox news, COO Dawn C. Willoughby sold 10,617 shares of Clorox stock in a transaction dated Wednesday, August 17th. The shares were sold at an average price of $131.01, for a total transaction of $1,390,933.17. Following the completion of the transaction, the chief operating officer now owns 20,353 shares in the company, valued at $2,666,446.53. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Laura Stein sold 38,882 shares of Clorox stock in a transaction dated Friday, September 2nd. The stock was sold at an average price of $131.69, for a total transaction of $5,120,370.58. Following the transaction, the executive vice president now owns 48,501 shares of the company’s stock, valued at approximately $6,387,096.69. The disclosure for this sale can be found here. Company insiders own 2.09% of the company’s stock.

A number of institutional investors have recently made changes to their positions in CLX. Norges Bank acquired a new position in shares of Clorox during the fourth quarter worth about $98,583,000. Bank of Montreal Can purchased a new position in Clorox during the second quarter worth $53,902,000. BlackRock Institutional Trust Company N.A. raised its position in Clorox by 8.6% in the second quarter. BlackRock Institutional Trust Company N.A. now owns 4,890,145 shares of the company’s stock worth $676,747,000 after buying an additional 385,723 shares in the last quarter. Prudential Financial Inc. raised its position in Clorox by 209.8% in the first quarter. Prudential Financial Inc. now owns 540,279 shares of the company’s stock worth $68,107,000 after buying an additional 365,910 shares in the last quarter. Finally, Emerald Acquisition Ltd. purchased a new position in Clorox during the second quarter worth $45,921,000. Institutional investors own 70.26% of the company’s stock.

About Clorox

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

5 Day Chart for NYSE:CLX

Receive News & Ratings for Clorox Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Co. and related companies with MarketBeat.com's FREE daily email newsletter.